The immunocompromised patient and transfusion

Postgraduate Medical Journal

Volumn 77, Issue 906, 2001, Pages 230-234

  Badami, K G ^a  

^a Jeevan Blood Bank and Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ALLOIMMUNIZATION; BLOOD TRANSFUSION REACTION; CYTOMEGALIC INCLUSION BODY DISEASE; GRAFT VERSUS HOST REACTION; HEPATITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; LEUKOCYTE TRANSFUSION; REVIEW; TRANSFUSION;

BLOOD TRANSFUSION; CYTOMEGALOVIRUS INFECTIONS; GRAFT VS HOST DISEASE; HUMANS; IMMUNOCOMPROMISED HOST; OPPORTUNISTIC INFECTIONS;

EID: 0035057234     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.77.906.230     Document Type: Review

References (60)

1. Blood product support for patients undergoing chemotherapy and bone marrow transplantation for haematological malignancies
2. Posttransfusion graft-versus-host disease in infancy
3. Graft-versus-host reaction following blood product transfusion
4. Fatal graft-versus-host disease following transfusion of granulocytes from normal donors
5. Acute graft-versus host disease resulting from normal blood transfusion
6. Fatal graft versus host disease after platelet transfusions in a child with purine nucleoside phosphorylase deficiency
7. Transfusion-associated graft-versus-host disease and blood irradiation
8. Acquired bone marrow failure
9. Transfusion medicine
10. Transfusion-associated graft-versus-host disease in immunocompetent patients: Report of a fatal case associated with transfusion from a second degree relative and a survey of predisposing factors
11. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery
12. Post transfusion-associated graft-versus-host disease in immunocompetent patients after cardiac surgery in Japan
13. Fatal graft-versus-host disease following blood transfusion in Hodgkin's disease documented by HLA typing
14. Transfusion associated graft-versus-host disease
15. Posttransfusion graft-versus-host disease in Japanese newborns
16. Human posttransfusion graft-versus-host disease
17. The mechanisms of leukocyte removal by filtration
18. Radiosensitivity of T and B lymphocytes. II. Effect of irradiation on response of T cells to alloantigens
19. The effects of irradiation on blood components
20. Blood and blood product transfusion during bone marrow transplantation
21. Effective ultraviolet irradiation of platelet concentrates in Teflon bags
22. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery
23. Impact of leucocyte-depleted blood components on the haematological recovery and prognosis of patients with acute myeloid leukaemia
24. Perioperative blood transfusion and outcome after resection for colorectal carcinoma
25. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: The importance of the timing of the leukodepletion
26. Transfusion-associated cancer recurrence and postoperative infection: Meta analysis of randomized controlled clinical trials
27. Indications for the use of cytomegalovirus-seronegative blood products
28. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
29. Prevention of cytomegalovirus following bone marrow transplantation: A randomized clinical trial of blood product screening
30. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: Filtration versus the use of seronegative donor units
31. International forum; transfusion transmitted CMV infections
32. The risk of cytomegalovirus infection in solid organ and bone marrow transplant recipients: Transfusion of blood products
33. Biologic effects of leukocytes present in transfused cellular blood products
34. Systematic use of leukocyte-free blood components to prevent alloimmunization and platelet refractoriness in multitransfused patients with cancer
35. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components
36. Role of leukodepletion in the control of transfusion-transmitted disease
37. Bacteria in blood for transfusion: A review
38. Transfusion related acute lung injury caused by an NB2 granulocyte-specific antibody in a patient with thrombotic thrombocytopenic purpura
39. Quality of blood components filtered before storage and at the bedside: Implications for transfusion practice
40. The role of plasma from platelet concentrates in transfusion reactions
41. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction
42. The presence of free infectious cytomegalovirus (CMV) in the plasma of donated CMV-seropositive blood and platelets
43. Apparent removal of graft-versus-leukaemia effect by the use of leukocyte-poor blood components in patients with acute myeloblastic leukaemia
44. Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor therapy
45. Reducing the risk for transfusion-transmitted cytomegalovirus infection
46. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma
47. Infection prophylaxis in marrow transplant recipients - Myths, legends and microbes
48. Epstein-Barr virus (EBV)-induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation
49. Cytomegalovirus and other herpesviruses
50. Transmission of human parvovirus B19 by coagulation factor concentrates
51. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-I): A treatable cause of anaemia in AIDS
52. Chronic bone marrow failure due to persistent B19 parvovirus infection
53. Persistent B19 parvovirus infection as a cause of severe anaemia in children with acute lymphoblastic leukaemia in remission
54. Transient erythroblastopenia of childhood with megakaryocytopenia associated with human parvovirus B19 infection
55. Human parvoviruses: Implications for transfusion medicine